SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX: 1777)

Market Cap	4.15B
Revenue (ttm)	1.22B
Net Income (ttm)	327.48M
Shares Out	44.59M
EPS (ttm)	7.33
PE Ratio	12.70
Forward PE	n/a
Dividend	3.50 (3.76%)
Ex-Dividend Date	Jul 19, 2024

Volume	26,492
Open	93.50
Previous Close	94.00
Day's Range	93.10 - 93.70
52-Week Range	81.70 - 106.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquil...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 220
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2023, SYN-TECH Chem. & Pharm.'s revenue was 1.11 billion, an increase of 13.02% compared to the previous year's 986.30 million. Earnings were 251.01 million, a decrease of -14.99%.